The Company of Biologists is delighted to announce a new three-year Read & Publish Open Access agreement with the Council of Australian University Librarians (CAUL).
The agreement commenced on 1 January 2022 and CAUL-member institutions in Australia and New Zealand can sign up on an annual basis in 2022, 2023 and 2024.
Researchers at participating institutions will be able to publish an uncapped number of articles immediately Open Access (OA) in The Company of Biologists’ prestigious hybrid journals – Development, Journal of Cell Science and Journal of Experimental Biology – without paying an article processing charge (APC). They will also benefit from unlimited access to the journals, including the full archive dating back to 1853.
Institutions also have the option to include uncapped APC-free publishing in The Company of Biologists’ fully Open Access journals – Disease Models & Mechanisms and Biology Open – in their Read & Publish agreement.
Angus Cook, Director, Content Procurement at CAUL, says:“Having a Read & Publish agreement with The Company of Biologists, commencing in 2022, is an important continuation of CAUL’s progression to providing broader Open Access arrangements via consortium agreements. The agreement is useful not only for the access it gives to content across the biological sciences used by CAUL members, but also the ability to publish OA in these subject areas which will be highly valued for locally produced research. Agreements with organisations such as The Company of Biologists also confirm CAUL’s commitment to work with publishers of all sizes.”
Rich Blount, Regional Sales Manager at The Company of Biologists, says:
“We are very excited to have signed our first ever consortium agreement with CAUL, particularly as it is also our first agreement in the Asia-Pacific region. Nine institutions in Australia and New Zealand were already participating in our Read & Publish initiative in 2021, and we hope that this new agreement will encourage many more to do so in 2022.”
Claire Moulton, Publisher at The Company of Biologists, says:“The Company of Biologists has been committed to Open Access publishing since 2004 and we have a track record of innovation. Our journals were the first in the world to be awarded Transformative Journal status by Plan S. Researchers at over 400 institutions in more than 30 countries are benefitting from APC-free OA publishing through our cost-neutral Read & Publish initiative, and we exceeded our public commitment to grow OA content by 5% during 2021. We welcome our new partnership with CAUL and look forward to working together to further accelerate OA publishing in the biological and biomedical sciences in Australia and New Zealand.”